Earlier today he showed up. A few minutes ago he spoke:
He spoke about the “learning curve” he’ll have with the hitters,
specifically expanding his pool of pupils from two or three hitters to
the 13 or more that he’ll have to work with here in spring. He spoke
about the “regrets” he has from his playing career and steroid-use. And
he stressed that he is ready to “move on” from his admission, even as
he understands the questions will linger.
Asked how long he will be asked these questions, he responded:
“That’s up to you guys. I’ve accepted responsibility. I can’t tell you
how many times that I’m truly sorry. It’s a very, very regrettable
situation that I put myself in. I’m just ready to move on, and I hope
everybody else can. It would be a better place if we move on and make
this a positive thing.”
McGwire also said — again — that insofar as they allowed him to play more often, yes, steroids helped him hit home runs. He stuck to his guns, however, and said that the ability to hit home runs was his own. Which is a perfectly legitimate and understandable opinion for McGwire to have of the matter. If anyone wants to continue to take issue with that it strikes me that they need to bring some actual scientific evidence regarding the effects of steroids on hitting. If they don’t, they’re complaining about McGwire’s opinions of himself, not his candor.
At any rate, it seems that at this point there is nothing more we can expect the man to say on the matter of his own personal steroid history. He has a job in baseball, and he’s trying to do it. If “questions linger” it’s only because the writers wish only to talk about the past.
The Dodgers have signed lefty Rich Hill to a three-year, $48 million contract.The deal was reported to be imminent over the weekend, but was finalized today following Hill’s physical.
Hill missed a good deal of time in 2016 with blister issues — and he’ll be 37-years-old on Opening Day — but when he was healthy he was fantastic, posting the best season in his 12-year career. He had a a 2.12 ERA and 129 strikeouts in 110.1 innings between the Athletics and Dodgers.
Along with a healthy Clayton Kershaw a maturing Julio Urias and Kenta Maeda, the Dodgers rotation looks to be a strength in 2017.
UPDATE: Buster Olney reports that a deal is in place pending a physical. The financial terms are not yet known. UPDATE: Joel Sherman of the New York Post hears it’s in the four-year, $62 million range. That will make him, temporarily at least, the highest-paid closer in baseball history.
12:15 PM: Ken Rosenthal reports that the San Francisco Giants are close to a deal with closer Mark Melancon.
Melancon had an outstanding 2016, posting a 1.64 ERA, 2.42 FIP and a 5.42 K/BB rate in 71.1 innings while saving 47 games for the Pirates and Nationals. You may recall that the Giants had a strong interest in Melancon last summer. It was a well-founded interest given the bullpen woes which waylaid San Francisco in the second half of last season and continued on into the playoffs.
The terms of the apparently impeding deal will be known soon enough, but Rosenthal reported yesterday that Melancon was fielding offers in the four-years, $60 million range. That’s a lot for a closer, but it’ll probably look like a bargain compared to the deals signed with the other two top closers on the market, Aroldis Chapman and Kenley Jansen. Some have speculated that Chapman could get a deal closer to $100 million than $50 million, though that seems optimistic.
What the past couple of seasons have shown, however, is that having a top bullpen will get you very, very far in Major League Baseball. Champan may have been gassed at the end of Game 7, but he was essential to the Cubs’ World Series title. Powerful bullpens gave the Royals a title in 2015 and the Indians an AL pennant this past year. A weak one was, obviously, the Giants’ achilles heel.
Their great need at the back end of the pen, according to Rosenthal’s report, is apparently about to be filled.